A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19
Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reported in China and rigorous researches are going on for developing vaccine for the pandemic. This review was prepared by following PRISMA guidelines and used the resources from the Web of Science and PubM...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Pure and Applied Microbiology
2020-05-01
|
Series: | Journal of Pure and Applied Microbiology |
Subjects: | |
Online Access: | https://microbiologyjournal.org/a-review-of-potential-antiviral-drugs-and-vaccines-to-treat-covid-19/ |
Summary: | Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reported
in China and rigorous researches are going on for developing vaccine for the pandemic. This review was
prepared by following PRISMA guidelines and used the resources from the Web of Science and PubMed.
This research focuses on the niches of symptoms and vaccines for COVID-19. The research for vaccine
involves research for new vaccine and drug repurposing. Out of various drug repurposing options,
Remdesivir, and Favipiravir, Chloroquine and Lopinavir/Ritonavir were found to be the popular ones
for treating COVID-19 patients across the world. Even though there are concerns regarding asymptotic
patients, the most dominant symptoms of COVID-19 are fever and cough, followed by Dyspnoea and
muscle ache. This review concludes that the COVID-19 related research should focus on developing
immunity vaccines, and repurposing of drugs. Research on the problems of quarantine life, patient
monitoring, and usage of information technology in facing COVID-19 will improve the quality of patient
handling during the pandemic. The research on the effectiveness of various models of lockdown and
regulation of social life during lockdown periods, improving the safety of health care workers in the
workplace will definitely help the governments in their fight against COVID-19. |
---|---|
ISSN: | 0973-7510 2581-690X |